North American Neural Implants Market

North American Neural Implants Market Size, Share & Trends Analysis Report by Product (Deep Brain Stimulation (DCS), Spinal Cord Stimulation (SCS), and Vagus Nerve Stimulation (VNS)), by Application (Chronic Pain, Epilepsy, Parkinson's Disease (PD), and Others (Depression and Other Movement Disorders)), and by End-user (Hospitals, Outpatient Surgery Centers, and Specialized Neurological Centers (SNCs)) Forecast Period (2021-2027)
    Update Available - Forecast 2024-2030   

Published: May 2021 | Report Code: OMR2023490 | Category : Medical Devices | Delivery Format: /

The North American neural implants market is estimated to grow at a CAGR of 8.5% during the forecast period. North America is dominating the global neural implants market owing to the high prevalence of neurological disorders and technological innovations in the neural/brain implant devices. The growth in the region is mainly attributed to the increasing incidence of PD, chronic pain, epilepsy, and conditions such as obesity, depression, and a rise in surgical procedures for treating such diseases. Furthermore, the availability of advanced healthcare infrastructure and constant technological innovations, and growing acceptance for technologically advanced neural implants are also accelerating the market growth in the region.

Further, epidemiological studies reported, an estimated 60,000 Americans are diagnosed with PD every year. Studies have also estimated, about one million people in the US alone will be living with PD by the end of 2020. In addition, the National Center for Health Statistics reported, around 25% of American adults suffer from chronic LBP. Also, according to the CDC, in 2016, approximately 20.4% of the US adults had chronic pain, and 8.0% of the US adults suffered from high-impact chronic pain with higher prevalence associated with the increasing age of the population.

The North American neural implants market is segmented based on product, application, and end-user. Based on the product, the neural implants market is segmented deep brain stimulation (DCS), spinal cord stimulation (SCS), and vagus nerve stimulation (VNS). Based on application, the market is classified into Chronic Pain, Epilepsy, Parkinson's Disease (PD), and others (depression and other movement disorders). Based on end-user, the market is segmented into hospitals, outpatient surgery centers, and specialized neurological centers (SNCs). 

Further, vendors are focusing on developing innovative and advanced products that will offer improved treatment outcomes using neural implants. HCPs are recommending treatment for PD, chronic pain, and other neural disorders using neural implants such as DBD, SCS, and VNS. Therefore, the accuracy and effectiveness of neural implants to reduce the risks of neurological disorders is influencing the neural implants market in North America.

Research Methodology

The market study of the North American neural implants market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity in our reports.

Secondary Sources Include

  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

  1. North American Neural Implants Market Research and Analysis by Product
  2. North American Neural Implants Market Research and Analysis by Application
  3. North American Neural Implants Market Research and Analysis by End-user

The Report Covers

  • Comprehensive research methodology of the North American neural implants market.
  • This report also includes a detailed and extensive market overview with the key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the North American neural implants market.
  • Insights about market determinants which are stimulating the North American neural implants market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

1. Report Summary

1.1. Research Methods and Tools

1.2. Market Breakdown

1.2.1. By Segments

1.2.2. By Geography

2. Market Overview and Insights

2.1. Scope of the Report

2.2. Analyst Insight & Current Market Trends

2.2.1. Key Findings

2.2.2. Recommendations

2.2.3. Conclusion

2.3. Rules & Regulations

3. Competitive Landscape

3.1. Key Strategy Analysis

3.2. Key Company Analysis

3.2.1. Overview

3.2.2. Financial Analysis

3.2.3. SWOT Analysis

3.2.4. Recent Developments

4. Market Determinants 

4.1 Motivators

4.2 Restraints

4.1. Opportunities 

5. Market Segmentation

5.1. North American Neural Implants Industry Market by Product

5.1.1. Deep Brain Stimulation (DCS)

5.1.2. Spinal Cord Stimulation (SCS)

5.1.3. Vagus Nerve Stimulation (VNS)

5.2. North American Neural Implants Market by Application

5.2.1. Chronic Pain

5.2.2. Epilepsy

5.2.3. Parkinson's Disease (PD)

5.2.4. Others (Depression and Other Movement Disorders)

5.3. North American Neural Implants Market by End-user

5.3.1. Hospitals

5.3.2. Outpatient Surgery Centers

5.3.3. Specialized Neurological Centers (SNCs)

6. Regional Analysis

6.1. The US

6.2. Canada

7. Company Profiles

7.1. Abbott

7.2. Boston Scientific Corporation

7.3. Functional Neuromodulation Ltd.

7.4. LivaNova PLC

7.5. Medtronic

7.6. Nalu Medical, Inc.

7.7. NEVRO CORP. 

7.8. NEURALINK*

7.9. NeuroPace, Inc.

7.10. NeuroSigma, Inc.

7.11. Nuvectra Medical

7.12. Renishaw plc

7.13. Saluda Medical Pty Ltd.

7.14. SetPoint Medical Corp.*

7.15. Stimwave LLC

7.16. Synchron, Inc.*

*-Investigational Companies

1. NORTH AMERICAN NEURAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)

2. NORTH AMERICAN NEURAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)

3. NORTH AMERICAN NEURAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)

4. NORTH AMERICAN NEURAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)

1. NORTH AMERICAN NEURAL IMPLANTS MARKET SHARE BY PRODUCT, 2020 VS 2027 (%)

2. NORTH AMERICAN NEURAL IMPLANTS MARKET SHARE BY APPLICATION, 2020 VS 2027 (%)

3. NORTH AMERICAN NEURAL IMPLANTS MARKET SHARE BY END-USER, 2020 VS 2027 (%)

4. NORTH AMERICAN NEURAL IMPLANTS MARKET SHARE BY COUNTRY, 2020 VS 2027 (%)

5. THE US NEURAL IMPLANTS MARKET SIZE, 2020-2027 ($ MILLION)

6. CANADA NEURAL IMPLANTS MARKET SIZE, 2020-2027 ($ MILLION)